Save time, refresh your knowledge, and on-board your colleagues using the resource pages provided here. Check out our drug discovery resources page for a high-level overview of resources available.
-
- Reference
- Sponsored
Minimum Viable Experiments with Imperfect Molecules: a Minipump Minireview
Optimizing lead compounds to have drug candidate-like qualities are time-consuming and expensive. Oftentimes, critical drug discovery project questions, such…10 mins read
-
- Reference
- Sponsored
Why pKas Matter in Medicinal Chemistry and a Drug Discovery Amine pKa Table
In this article, we highlight the importance of pKa values in medicinal chemistry and drug discovery and provide a…6 mins read
-
- Industry Reviews
2021 Drug Discovery Biotech Mergers and Acquisitions Review
We reviewed all of the biotech mergers and acquisitions in 2021 and did a deep dive on the list…1 min read
-
- Reference
What Makes a Drug Best-in-Class?
How a Follow-on Drug Can Create Value After a First-in-Class Drug Novel drugs can make a big impact in…4 mins read
-
- Reference
An Introduction to Fragment-Based Drug Discovery (FBDD)
In this minireview, Dr. Romyr Dominique introduces three key concepts in fragment-based drug discovery and shares his favorite articles…8 mins read
-
- Reference
AICs and PAINS: Mechanisms of Assay Interference
In this minireview, Drs. Jayme L. Dahlin and Michael A. Walters summarize the different mechanisms by which molecules can…10 mins read
-
- Reference
What is an IND? What is a Clinical Hold? Why Do Clinical Holds Happen?
In this article, Dr. Thuy Tran, a CMC Project Leader at Servier, gives us a quick explanation of what…8 mins read
-
- Reference
Practical PK Calculators
This page contains Drug Hunter's practical PK calculators useful for day-to-day drug discovery, including a PK unit converter such…2 mins read
-
- Reference
- Sponsored
Solid Form Strategies for Increasing Oral Bioavailability
Small-molecule drug candidates are increasingly falling “beyond the rule of 5,” making oral administration more challenging. Optimizing a drug’s…4 mins read
RECENT ARTICLES
- Small Molecule and Biotechnology-Based Therapeutics for Neurology-Focused Companies: 2021’s IPOs Part V
- Agile Drug Hunting
- Lenacapavir Synthesis Highlights
- June 2022 Molecules of the Month Runners-Up
- Molecules of the Month – June 2022
- Beginning with the End in Mind: Five Minutes with a Commercial Leader
DRUG DISCOVERY RESOURCES
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet
- Phase I Drug Metabolism
- Approved Covalent Drug Mechanisms
- Why LogD Matters / LogD Poster
- Types of Kinase Inhibitors
- Unusual Molecular Interactions from the PDB
- Bioactivation of Structural Alerts
- The Square Cube Law
- Don’t Work on Things That Don’t Work
- What is a Biologic Drug Anyway?
- Managing Liver Injury (DILI) Risk
- Where Do Hits Come From?
JOIN SUBSCRIBERS from
- Johnson & Johnson
- Roche
- Pfizer
- Novartis
- Bayer
- Merck
- Sanofi
- GlaxoSmithKline
- AbbVie
- Eli Lilly
- Boehringer Ingelheim
- Amgen
- Bristol-Myers Squibb
- Gilead
- AstraZeneca
- Teva
- Novo Nordisk
- Merck KGaA
- Takeda
- Celgene (BMS)
- Biogen
- Astellas
- Daiichi Sankyo
- Regeneron
- UCB
- Eisai
- Servier
- Kyowa Kirin
- Shionogi
- Vertex
- Lundbeck
- Taisho
- Ono
- Seagen
- Incyte
- LEO Pharma
- Janssen
- Galapagos
- Idorsia
- Astex
- Arvinas
- Kymera
- Relay
- Schrodinger
- Mirati
- Revolution
- Nimbus
- Plexxikon
- Forma
- Arcus
- RA Capital
- ARCH Venture Partners
- MPM Capital
- Orbimed
- The Column Group
- 5AM Ventures
- Versant Ventures
- Deerfield
- Goldman Sachs
- Citi
- Piper Sandler
- Softbank
- …and hundreds of others